A detailed history of R Squared LTD transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, R Squared LTD holds 38,765 shares of IRWD stock, worth $59,698. This represents 0.02% of its overall portfolio holdings.

Number of Shares
38,765
Previous 10,030 286.49%
Holding current value
$59,698
Previous $14.7 Million 88.56%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$0.57 - $1.44 $16,378 - $41,378
28,735 Added 286.49%
38,765 $27.8 Million
Q1 2025

May 09, 2025

BUY
$1.41 - $4.58 $7,106 - $23,083
5,040 Added 101.0%
10,030 $14.7 Million
Q4 2024

Jan 22, 2025

BUY
$3.34 - $5.04 $16,666 - $25,149
4,990 New
4,990 $22.1 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $236M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track R Squared LTD Portfolio

Follow R Squared LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R Squared LTD, based on Form 13F filings with the SEC.

News

Stay updated on R Squared LTD with notifications on news.